Welcome to Optogenetics Australia!

Optogenetics Australia was established to support the application and development of optogenetics and deliver benefits of the technology to research in academia and industry in Australia. This network will foster exchange and collaboration by connecting research groups working in the field and by organizing an annual workshop. Find out more about optogenetics and investigators in Australia! The upcoming virtual workshop is scheduled for 16-19 February 2021 and registration and abstract submission are now open! Impressions from our inaugural 2020 workshop can be found here.

Applications of optogenetics are rapidly expanding in research and therapy:

>6000

Publications in PubMed

2006-2020:

„Optogenetic(s)“ in title/abstract

>800

mentions in WIPO Patent(s) (applications)

August 2020:

http://patents.google.com/?q=optogenetics&country=WO

THREE

Clinical Trials using ChR

August 2020:

http://clinicaltrials.gov/ct2/results?term=channelrhodopsin

For inquiries or if you would like to contribute to Optogenetics Australia, please contact Harald Janovjak (Monash University, chair) by email.

Optogenetics Australia advisory board: Zane Andrews (Monash University), Chris Dayas (University of Newcastle), Wendy Imlach (Monash University), Mark Hutchinson (University of Adelaide), Abbas Kouzani (Deakin University), John Lin (University of Tasmania), Gavan McNally (University of New South Wales), Ethan Scott (University of Queensland), Alexandra Tichy (Monash University)